The Patent Finder

Encycle Therapeutics Inc.

Also on record
Records under this name other than patents Encycle Therapeutics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 7 of 7 · Back to Encycle Therapeutics Inc.

PatentTitleStatus Expires Confidence
US 11,072,616Cyclic peptides targeting alpha-4-beta-7 integrin
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,713,338Cyclic peptides multimers targeting α-4-β-7 integrin
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,077,611Cyclic peptides multimers targeting α4β7 integrin
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,111,273Cyclic peptides multimers targeting alpha-4-beta-7 integrin
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,286,281Homodetic cyclic peptides targeting alpha-4-beta-7 integrin
Formerly held
Lapsed on the fee record
Ended Mar 29, 2026 · From the USPTO record
Lapsed on the fee recordEnded Mar 29, 2026From the USPTO record
US 11,046,695Fragment synthesis of substituted cyclic peptides
Formerly held
Lapsed on the fee record
Ended Jun 29, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jun 29, 2025From the USPTO record
US 10,981,921Fragment synthesis of substituted cyclic peptides
Formerly held
Lapsed on the fee record
Ended Apr 20, 2025 · From the USPTO record
Lapsed on the fee recordEnded Apr 20, 2025From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited